Interventional Care

We notice that you are visiting us from . This site only services US-based visitors. Would you like to visit the site that is appropriate for your location?
PDI has been monitoring the COVID-19 pandemic (SARS-CoV-2) to provide you the most current information to help manage this outbreak. Over the past several months, there have been significant advances in the testing and approvals of disinfectants against the SARS-CoV-2 virus. In addition, on March 13, 2020, the CDC updated their recommendations to refer to List N on the EPA website. Per the EPA’s website, “EPA expects all products on List N to kill the coronavirus SARS-CoV-2 (COVID-19) when used according to the label directions.”
PDI product with EPA approval for the SARS-CoV-2 claim:
PDI products on EPA List N entitled Products with Emerging Viral Pathogens and Human Coronavirus claims for use against SARS-CoV-2:
This information is up-to-date as of May 13, 2021
* Achieved 3-log reduction against the virus